英文摘要 |
Lactosucrose (O-β-D-galactopyranosyl-(1→2)-β-D-fructofuranoside) has a series of physiological functions that are safe and nontoxic and have been proven to be health-promoting in vitro, in vivo, and in animal experiments. This new nutraceutical promotes intestinal health and aids cancer prevention. The development and use of this oligosaccharide has high academic and industrial value and is of considerable significance in improving human health. This study involved the preparation, separation, and purification of levansucrase and its use in free and immobilized forms to synthesize lactosucrose. Precipitation, and DEAE-Sepharose and Source 15Q anion exchange chromatography were used to obtain the purified enzyme. The final purification ratio, recovery, and specific activity were 24.0, 43.7%, and 300.1 U/mg, respectively. The purified sample was subjected to SDS-PAGE analysis, and the estimated molecular weight of the enzyme was approximately 32.5 kDa. For the free enzyme, the optimal production conditions of lactosucrose were free enzyme = 2.5 U, sucrose:lactose (1:1) concentration = 100 g/L, temperature = 27°C, and pH = 6. With the free enzyme, 35.8 g/L of lactosucrose was produced in 24 h (production rate, 35.8%; 1.49 g/L/h). For the immobilized enzyme, the optimal production conditions of lactosucrose were immobilized enzyme = 2 g (approximately 150 U), sucrose:lactose (1:1) concentration = 100 g/L, temperature = 27°C, and pH = 6. With the immobilized enzyme, 36.9 g/L of lactosucrose was produced in 24 h (production rate, 36.9%; 1.54 g/L/h). |